Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pyloricagA genotype

References

• Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 1996; 215(Suppl):3–10.
   Google Scholar
• Sobala GM, Crabtree JE, Dixon MF, Schorah CJ, Taylor JD, Rathbone BJ, et al. Acute Helicobacter pylori infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations. Gut 1991;32:1415–8.
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Peichl P, Wyatt JI, Stachl U, Lindley IJ. Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol 1993;37: 65–70.
   PubMed Web of Science ®Google Scholar
• Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29: 425–9.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110:1744–52.
   Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene-positive Helicobacter pylori strains. Gut 1997;41:442–51.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Tanahashi T, Kashima K, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998;42:609–17.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between clinical presentation, Helicobacter pylori density, interleukin-1β and -8 production and cagA status. Gut 1999;45:804–11.
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kodama T, Kita M, Imanishi J, Kashima K, Graham DY. Relation between cytokines and Helicobacter pylori in gastric cancer. Helicobacter 2001;6:116–24.
   PubMedGoogle Scholar
• Kabir S, Daar GA. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. Cancer Lett 1995;95:207–12.
   PubMed Web of Science ®Google Scholar
• Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998;152:93–100.
   PubMed Web of Science ®Google Scholar
• Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P’eng FK, et al. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996;91: 1417–22.
   Google Scholar
• Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at −511 in the human interleukin-1 ß gene. Hum Mol Genet 1992;1:450.
   PubMedGoogle Scholar
• Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998;43:33–9.
   PubMed Web of Science ®Google Scholar
• Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagnoist gene intron 2 is caused by variable numbers of an 86-base pair tandem repeat. Hum Genet 1993;91:403–4.
   PubMed Web of Science ®Google Scholar
• Kornman KS, Crane A, Wang HY, Di Giovine FS, Newman MG, Pirk FW, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 24:72–7.
   Google Scholar
• Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, et al. Interleukin-1 beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003;37:65–71.
   PubMedGoogle Scholar
• Greenstein G, Hart TC. A critical assessment of interleukin-1 (IL-1) genotyping when used in a genetic susceptibility test for severe chronic periodontitis. J Periodontol 2002;73:231– 47.
   PubMedGoogle Scholar
• Dore MP, Graham DY. Ulcers and gastritis. Endoscopy 2004;36:42–7.
   PubMedGoogle Scholar
• El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404: 398–402.
   Google Scholar
• Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680–7.
   PubMed Web of Science ®Google Scholar
• Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823–9.
   PubMed Web of Science ®Google Scholar
• Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364–71.
   PubMed Web of Science ®Google Scholar
• Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, et al. Effect of interleukin-1 polymorphisms on gastric mucosal interleukin-1 ß production on Helicobacter pylori infection. Gastroenterology 2002;123:1793–803.
   PubMed Web of Science ®Google Scholar
• Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92–105.
   PubMed Web of Science ®Google Scholar
• Wallace JL, Cucala M, Mugridge K, Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991;261:G559–64.
   PubMed Web of Science ®Google Scholar
• Wolfe MM, Nompleggi DJ. Cytokine inhibition of gastric acid secretion: a little goes a long way. Gastroenterology 1992;102:2177–8.
   PubMedGoogle Scholar
• Rad R, Prinz C, Neu B, Neuhofer M, Zeitner M, Voland P, et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 2003;188:272–81.
   PubMed Web of Science ®Google Scholar
• Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082–9.
   PubMed Web of Science ®Google Scholar
• Zambon CF, Basso D, Navaglia F, Germano G, Gallo N, Milazzo M, et al. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002;18:242–51.
   PubMed Web of Science ®Google Scholar
• Chang YT, Wu MS, Shun CT, Lin MT, Chang MC, Lin JT Association of polymorphisms of interleukin-1 beta gene and Helicobacter pylori infection with the risk of gastric ulcer. Hepatogastroenterology 2002;49:1474–6.
   PubMedGoogle Scholar
• Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, et al. Helicobacter pylori in North and South America before Columbus. FEBS Lett 2002;517:180–4.
   PubMed Web of Science ®Google Scholar
• Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y. Molecular epidemiology of Helicobacter pylori from a population cross roads: Thailand. Helicobacter 2004;9:453–9.
   PubMed Web of Science ®Google Scholar
• Park CY, Cho YK, Kodama T, El-Zimaity HM, Osato MS, Graham DY, et al. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 2002;40:4753–6.
   Google Scholar
• Vilaichone RK, Mahachai V, Kositchaiwat C, Graham DY, Yamaoka Y. Relation between seroreactivity to low molecular weight specific Helicobacter pylori antigens and disease presentation. Clin Diag Lab Immun 2003;10:1025–8.
   Google Scholar
• Miyabayashi H, Furihata K, Shimizu T, Ueno I, Akamatsu T. Influence of oral Helicobacter pylori on the success of eradication therapy against gastric Helicobacter pylori. Helicobacter 2000;5:30–7.
   Google Scholar
• Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, et al. Relationship between subtypes of the cagA 3′ repeat region, gastric histology, and susceptibility to low pH. Gastroenterology 1999;117:342–9.
   PubMed Web of Science ®Google Scholar
• Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al. Genetic differences in interleukin-1 beta polymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res 2003;22:47–55.
   PubMedGoogle Scholar
• Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002;99:14428–33.
   PubMed Web of Science ®Google Scholar